JPRN-UMIN000025246已完成未知
Safety and efficacy of indigo naturalis for chronic enteropathy associated with SLCO2A1 and Cronkhite-Canada syndrome. - Safety and efficacy of indigo naturalis for chronic enteropathy associated with SLCO2A1 and Cronkhite-Canada syndrome.
Keio University Gastroenterology and Hepatology0 个研究点目标入组 6 人开始时间: 2016年12月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 69years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients who meet the following criteria are excluded. 1 The patients have stricture of the digestive tract. 2 The patients plans to undergo surgery. 3 The patients have severe infection. 4 The patients have severe heart failure. 5 The patients have serum Creatinine above 2. 6 The patients have T.Bil above 2.0, AST above 50, or ALT above 50. 7 The patients have malignancy or past history of malignancy. 8 The patients have neuropsychiatric disorder. 9 Women who are or may be pregnant, nursing women and woman who desire to bear children. 10 Inappropriate patients by doctor's judgement. 11 The patients who received other traditional chinese medicine inside 2 weeks.
研究者
相似试验
招募中
3 期
IN for practical useulcertive colitisJPRN-jRCTs031190156Kanai Takanori100
已完成
不适用
The efficacy of indigo naturalis-containing suppository in patients with active ulcerative colitis.ulcerative colitisJPRN-UMIN000029633Keio University School of Medicine10
招募中
不适用
Investigation of the safety of Indigo naturalis for the patients with ulcerative colitisulcerative colitisJPRN-UMIN000017359Osaka University, Graduate School of Medicine, Department of Gastroenterology and Hepatology20
已完成
不适用
Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19COVID-19SARS-CoV2Disease PreventionCoronavirus InfectionsSARS VirusCoronaviridae InfectionsNidovirales InfectionsBetacoronavirusRPCEC00000352Center for Technological Applications and Nuclear Development (CEADEN)148
已完成
不适用
Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19COVID-19SARS-CoV2Nidovirales InfectionsCoronaviridae InfectionsCoronavirus InfectionsSARS VirusDisease PreventionBetacoronavirusRPCEC00000351Center for Technological Applications and Nuclear Development (CEADEN)340